Clinical Evaluation of a GP5+/6+-Based Luminex Assay Having Full High-Risk Human Papillomavirus Genotyping Capability and an Internal Control

Clinical Validation of the HPV-Risk Assay, a Novel Real-Time PCR Assay for Detection of High-Risk Human Papillomavirus DNA by Targeting the E7 Region

(2014) A. T. Hesselink et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions

(2014) Jack Cuzick et al.   JOURNAL OF CLINICAL VIROLOGY

HPV genotype distribution according to severity of cervical neoplasia using the digene HPV genotyping LQ test

(2013) Philippe Halfon et al.   ARCHIVES OF VIROLOGY

Clinical evaluation of high-risk HPV detection on self-samples using the indicating FTA-elute solid-carrier cartridge

(2013) D.T. Geraets et al.   JOURNAL OF CLINICAL VIROLOGY

Human papillomavirus type-specific persistence and recurrence after treatment for cervical dysplasia

(2013) Anna Söderlund-Strand et al.   JOURNAL OF MEDICAL VIROLOGY

Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study

(2012) J. Thomas Cox et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Clinical Validation of a Type-Specific Real-Time Quantitative Human Papillomavirus PCR against the Performance of Hybrid Capture 2 for the Purpose of Cervical Cancer Screening

(2012) C. E. Depuydt et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

(2012) Marc Arbyn et al.   VACCINE

Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada

(2012) G.S. Ogilvie et al.   VACCINE

Universal human papillomavirus genotyping by the digene HPV Genotyping RH and LQ Tests

(2011) D.T. Geraets et al.   JOURNAL OF CLINICAL VIROLOGY

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

(2011) Dorien C Rijkaart et al.   LANCET ONCOLOGY

Performance of the digene LQ, RH and PS HPVs genotyping systems on clinical samples and comparison with HC2 and PCR-based Linear Array

(2011) Jose M Godínez et al.   Infectious Agents and Cancer

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition--Summary Document

(2010) M. Arbyn et al.   ANNALS OF ONCOLOGY

Highlights of the 26th International Papillomavirus Conference and Workshops

(2010) Marc Arbyn et al.   Future Oncology

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

(2010) Silvia de Sanjose et al.   LANCET ONCOLOGY

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

(2010) Guglielmo Ronco et al.   LANCET ONCOLOGY

High-throughput genotyping of high-risk HPV by the digene HPV Genotyping LQ Test using GP5+/6+-PCR and xMAP technology

(2009) D.T. Geraets et al.   JOURNAL OF CLINICAL VIROLOGY

Efficacy of HPV DNA Testing With Cytology Triage and/or Repeat HPV DNA Testing in Primary Cervical Cancer Screening

(2009) P. Naucler et al.   JNCI-Journal of the National Cancer Institute

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial

(2009) Henry C Kitchener et al.   LANCET ONCOLOGY

A review of human carcinogens—Part B: biological agents

(2009) Véronique Bouvard et al.   LANCET ONCOLOGY

HPV Screening for Cervical Cancer in Rural India

(2009) Rengaswamy Sankaranarayanan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

(2008) Chris J.L.M. Meijer et al.   INTERNATIONAL JOURNAL OF CANCER